Pfizer CentreOne CPhI Barcelona Pfizer CentreOne CPhI Barcelona

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about CSL Vifor aggregated by PharmaCompass.com.

    Client Virtual Booth

    CSL VIFOR

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    CSL Vifor
    Switzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Flughofstrasse 61, P.O. Box CH-8152 Glattbrugg
    Telephone
    Telephone
    +41 58 851 80 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viforpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vifor-pharma
    Twitter
    Twitter
    https://www.twitter.com/CSLVifor/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    left grey arrow
    right gray arrow
    Full View ScreenFull Screen View
    Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines
    Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines

    https://www.prnewswire.com/news-releases/ferinject-granted-upgraded-recommendations-in-2023-esc-heart-failure-guidelines-301911066.html

    PR NEWSWIRE
    28 Aug 2023
    Share Share
    Vifor's Tavneos (avacopan) Receives Approval in Europe
    Vifor's Tavneos (avacopan) Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    19 Jul 2023
    Share Share
    Kapruvia recommended by NICE for the treatment of CKD-associated pruritus
    Kapruvia recommended by NICE for the treatment of CKD-associated pruritus

    https://www.prnewswire.com/news-releases/kapruvia-difelikefalin-recommended-by-englands-nice-for-the-treatment-of-adults-with-moderate-to-severe-ckd-associated-pruritus-301827524.html

    PR NEWSWIRE
    19 May 2023
    Share Share
    Tavneos included in updated EULAR recommendations for the management of AAV
    Tavneos included in updated EULAR recommendations for the management of AAV

    https://www.prnewswire.com/news-releases/tavneos-avacopan-included-in-updated-eular-recommendations-for-the-management-of-aav-301782385.html

    PR NEWSWIRE
    27 Mar 2023
    Share Share
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe
    Vifor Pharma's Tavneos (Avacopan) Approved In Europe

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    13 Feb 2023
    Share Share
    Cancellation of remaining publicly held registered shares of Vifor Pharma AG
    Cancellation of remaining publicly held registered shares of Vifor Pharma AG

    https://www.businesswire.com/news/home/20221213005876/en

    BUSINESSWIRE
    14 Dec 2022
    Share Share
    Vifor's Velphoro Receives Approval in Europe
    Vifor's Velphoro Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/velphoro-epar-medicine-overview_en.pdf

    EMA
    08 Dec 2022
    Share Share
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe
    Vifor's Tavneos (Avacopan) Receives Approval in the Europe

    https://www.ema.europa.eu/en/documents/overview/tavneos-epar-medicine-overview_en.pdf

    EMA
    25 Nov 2022
    Share Share
    Two Aurinia execs are out — and CRISPR’s operations chief isn't far behind
    Two Aurinia execs are out — and CRISPR’s operations chief isn't far behind

    https://endpts.com/two-aurinia-execs-are-out-and-crisprs-operations-chief-isnt-far-behind-biogen-ms-leader-jumps-to-eli-lilly-partner/

    Alex Hoffman ENDPTS
    28 Oct 2022
    Share Share
    Approval of extension of exemptions from SIX disclosure & publicity obligations
    Approval of extension of exemptions from SIX disclosure & publicity obligations

    https://www.businesswire.com/news/home/20221019006063/en

    BUSINESSWIRE
    20 Oct 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    seqens-2023-10-02

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search